Trial intelligence / Profile preview

Safety and Immunogenicity of Fluzone (2006-2007) in Children

NCT00390884Phase 4Completed

Sponsor
Sanofi
Start
Oct 2006
Primary completion
Jun 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Fluzone Trivalent in influenza, sponsored by Sanofi. Started Oct 2006; status: completed.

02

Drugs

Fluzone Trivalent
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00390884.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00390884.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call